June 19, 2017

Belcher Pharmaceuticals, LLC v. Hospira, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. February 04, 2022

    Belcher Must Cover Hospira's Legal Fees In Patent Fight

    A Delaware federal judge has ordered Belcher Pharmaceuticals to foot the bill for Pfizer unit Hospira in Belcher's patent infringement suit over epinephrine injector Abboject, finding that the accuser's antics during the litigation — and the "weak" suit it lodged — called for the company to cover Hospira's fees.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!